189.465
0.215 (0.11%)
0.215 (0.11%)
Upgrade to Real-Time
Regular Market
Low
129.21
High
218.00
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Eli Lilly and Co | LLY | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.215 | 0.11% | 189.465 | 14:59:41 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 188.67 | 188.07 | 190.88 | 189.25 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 23,787 | 1,609,640 | $ 189.50 | $ 305,022,064 | 4,878,199 | 129.21 - 218.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:59:41 | 100 | $ 189.465 | USD |
Eli Lilly Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 181.24B | 956.58M | 789.00M | $ 22.32B | $ 5.32B | 8.77 | 33.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 2.58 | 1.36% | - | - |
Eli Lilly News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LLY Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 183.00 | 190.88 | 180.88 | 184.82 | 2,854,241 | 6.47 | 3.53% |
| 1 Month | 184.29 | 190.88 | 179.82 | 184.31 | 2,868,050 | 5.18 | 2.81% |
| 3 Months | 208.24 | 218.00 | 179.82 | 197.36 | 3,787,097 | -18.78 | -9.02% |
| 6 Months | 147.19 | 218.00 | 129.21 | 175.92 | 4,104,626 | 42.28 | 28.72% |
| 1 Year | 156.67 | 218.00 | 129.21 | 165.86 | 3,757,929 | 32.80 | 20.93% |
| 3 Years | 78.96 | 218.00 | 77.09 | 130.43 | 4,887,447 | 110.51 | 139.95% |
| 5 Years | 77.58 | 218.00 | 64.18 | 113.20 | 4,411,194 | 111.89 | 144.22% |
Eli Lilly Description
| Eli Lilly is a drug company with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta and Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology. |
